These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 11098553)

  • 1. [Pathogenesis of coronary disease].
    Dietze GJ; van Erckelens F; Bunse M; Jung WI
    Z Kardiol; 2000; 89 Suppl 7():7-10. PubMed ID: 11098553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [On pathogenesis of coronary heart disease].
    Dietze GJ; van Erckelens F; Bunse M; Jung WI
    Z Kardiol; 2000 Oct; 89(Suppl 7):VII7-VII10. PubMed ID: 27320537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The obesity epidemic: pathophysiology and consequences of obesity.
    Pi-Sunyer FX
    Obes Res; 2002 Dec; 10 Suppl 2():97S-104S. PubMed ID: 12490658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of obesity and consequent insulin resistance on coronary risk factors in medically treated patients with coronary disease.
    Ades PA; Savage PD; Toth MJ; Schneider DJ; Audelin MC; Bunn JY; Ludlow M
    Int J Obes (Lond); 2008 Jun; 32(6):967-74. PubMed ID: 18268512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between lipid abnormalities and insulin resistance in Japanese school children.
    Asato Y; Katsuren K; Ohshiro T; Kikawa K; Shimabukuro T; Ohta T
    Arterioscler Thromb Vasc Biol; 2006 Dec; 26(12):2781-6. PubMed ID: 16990559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lifestyle modification and endothelial function in obese subjects.
    Hamdy O
    Expert Rev Cardiovasc Ther; 2005 Mar; 3(2):231-41. PubMed ID: 15853597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Health effects of trans-fatty acids: experimental and observational evidence.
    Mozaffarian D; Aro A; Willett WC
    Eur J Clin Nutr; 2009 May; 63 Suppl 2():S5-21. PubMed ID: 19424218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The insulin resistance syndrome: mechanisms of clustering of cardiovascular risk.
    Chan JC; Tong PC; Critchley JA
    Semin Vasc Med; 2002 Feb; 2(1):45-57. PubMed ID: 16222595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-esterified fatty acids and blood pressure elevation: a mechanism for hypertension in subjects with obesity/insulin resistance?
    Sarafidis PA; Bakris GL
    J Hum Hypertens; 2007 Jan; 21(1):12-9. PubMed ID: 17051236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelial dysfunction in obesity and insulin resistance: a road to diabetes and heart disease.
    Caballero AE
    Obes Res; 2003 Nov; 11(11):1278-89. PubMed ID: 14627747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Obesity as the core of the metabolic syndrome and the management of coronary heart disease.
    Shirai K
    Curr Med Res Opin; 2004 Mar; 20(3):295-304. PubMed ID: 15025838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Obesity and disease management: effects of weight loss on comorbid conditions.
    Anderson JW; Konz EC
    Obes Res; 2001 Nov; 9 Suppl 4():326S-334S. PubMed ID: 11707561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The fatty acid transporter FAT/CD36 is upregulated in subcutaneous and visceral adipose tissues in human obesity and type 2 diabetes.
    Bonen A; Tandon NN; Glatz JF; Luiken JJ; Heigenhauser GJ
    Int J Obes (Lond); 2006 Jun; 30(6):877-83. PubMed ID: 16418758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble intercellular adhesion molecules, soluble vascular cell adhesion molecules, and risk of coronary heart disease.
    Shai I; Pischon T; Hu FB; Ascherio A; Rifai N; Rimm EB
    Obesity (Silver Spring); 2006 Nov; 14(11):2099-106. PubMed ID: 17135628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of obesity on the pathogenesis and prognosis of coronary heart disease.
    Todd Miller M; Lavie CJ; White CJ
    J Cardiometab Syndr; 2008; 3(3):162-7. PubMed ID: 18983333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Which obesity index best explains the link between adipokines, coronary heart disease risk and metabolic abnormalities in type 2 diabetes mellitus?
    Mojiminiyi OA; Al Mulla F; Abdella NA
    Med Princ Pract; 2009; 18(2):123-9. PubMed ID: 19204431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A long-term follow-up study of serum lipid levels and coronary heart disease in the elderly.
    Li JZ; Chen ML; Wang S; Dong J; Zeng P; Hou LW
    Chin Med J (Engl); 2004 Feb; 117(2):163-7. PubMed ID: 14975195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abdominal obesity is associated with increased risk of acute coronary events in men.
    Lakka HM; Lakka TA; Tuomilehto J; Salonen JT
    Eur Heart J; 2002 May; 23(9):706-13. PubMed ID: 11977996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Leptin to adiponectin ratio, as an index of insulin resistance and atherosclerosis development].
    Kieć-Klimczak M; Malczewska-Malec M; Huszno B
    Przegl Lek; 2008; 65(12):844-9. PubMed ID: 19441676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overweight Latino children and adolescents have marked endothelial dysfunction and subclinical vascular inflammation in association with excess body fat and insulin resistance.
    Caballero AE; Bousquet-Santos K; Robles-Osorio L; Montagnani V; Soodini G; Porramatikul S; Hamdy O; Nobrega AC; Horton ES
    Diabetes Care; 2008 Mar; 31(3):576-82. PubMed ID: 18083792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.